Pharsight

Safyral patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5798338 BAYER HLTHCARE Solid dosage forms that contain clathrates of 17α-ethinyl estradiol
Jul, 2015

(8 years ago)

US6441168 BAYER HLTHCARE Stable crystalline salts of 5-methyltetrahydrofolic acid
Apr, 2020

(4 years ago)

US6958326 BAYER HLTHCARE Cyclodextrin-drospirenone inclusion complexes
Dec, 2021

(2 years ago)

US7163931 BAYER HLTHCARE Compositions of estrogen-cyclodextrin complexes
Mar, 2022

(2 years ago)

US8617597 BAYER HLTHCARE Pharmaceutical composition containing a tetrahydrofolic acid
Feb, 2030

(5 years from now)

US11617751 BAYER HLTHCARE Pharmaceutical composition containing a tetrahydrofolic acid
Jul, 2030

(6 years from now)

Safyral is owned by Bayer Hlthcare.

Safyral contains Drospirenone; Ethinyl Estradiol; Levomefolate Calcium.

Safyral has a total of 6 drug patents out of which 4 drug patents have expired.

Expired drug patents of Safyral are:

  • US5798338
  • US6441168
  • US6958326
  • US7163931

Safyral was authorised for market use on 16 December, 2010.

Safyral is available in tablet;oral dosage forms.

Safyral can be used as prevention of pregnancy, raise folate levels in women who choose to use an oral contraceptive as their method of contraception for the purpose of reducing the risk of a neural tube defect in a pregnancy.

The generics of Safyral are possible to be released after 17 July, 2030.

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Dec 16, 2013

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM ingredient

Market Authorisation Date: 16 December, 2010

Treatment: Prevention of pregnancy; Raise folate levels in women who choose to use an oral contraceptive as their method of contraception for the purpose of reducing the risk of a neural tube defect in a pregnan...

Dosage: TABLET;ORAL

How can I launch a generic of SAFYRAL before it's drug patent expiration?
More Information on Dosage

SAFYRAL family patents

Family Patents